Encompass Health Corp EHC
Encompass Health Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($62.64); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Encompass Health Corp trades at about 22.5× earnings — above its 10-year norm (10-year range 11.9×–23.1×, median 18.1×).
Shaded band = 10-year range (11.9×–23.1×); dot = today's 22.5×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 12.4% | 13.9% | 15.8% | 13.3% | 13.0% | 14.8% | 16.1% |
| Net margin | 9.5% | 8.5% | 7.3% | 6.2% | 10.3% | 8.0% | 7.8% | 6.8% | 6.9% | 6.8% |
| FCF margin | — | — | — | 3.2% | 4.8% | 8.7% | 5.7% | 11.9% | 11.1% | 12.7% |
| Return on assets | 8.0% | 7.0% | 5.8% | 4.8% | 6.0% | 4.4% | 5.9% | 5.6% | 5.6% | 5.3% |
| Return on equity | 17.6% | 16.3% | 15.6% | 14.8% | 17.5% | 14.4% | 21.2% | 18.8% | 19.4% | 27.2% |
| Current ratio | 1.08 | 1.05 | 1.28 | 1.25 | 1.23 | 1.32 | 1.05 | 0.98 | 1.36 | 1.38 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.